Medicines for Malaria Venture (MMV) 34d ago

As malaria becomes more complex, treatment and prevention tools must become simpler. Progress against malaria has stalled. Meanwhile, drug resistance is rising, and climate change and conflict are making it harder to control and eliminate. This is where elimination accelerators come in, and they play a central role in MMV’s strategy to strengthen the antimalarial pipeline with the next generation of interventions. These include next-generation medicines that can overcome emerging drug resistance, simpler treatments that ideally require fewer doses or even a single-dose cure, and longer-acting prevention that can protect people through an entire malaria season. How do they work? Fewer doses make treatment easier to complete. Better completion increases the likelihood of fully clearing parasites. Fully clearing parasites helps limit transmission and the spread of resistance. Because accelerating elimination requires interventions people can actually use and complete.